Sangamo Therapeutics (SGMOQ) Non Operating Income (2010 - 2012)

Sangamo Therapeutics' Non Operating Income history runs 3 years deep, the most recent figure standing at -$109000.0 for Q4 2012.

• On a quarterly basis, Non Operating Income fell 1916.67% year-over-year to -$109000.0 in Q4 2012; TTM through Dec 2012 was -$66000.0, a 192.96% decrease from a year earlier, with the FY2014 full-year figure at $364000.0, up 343.9% from the prior year.
• Non Operating Income fell to -$109000.0 in Q4 2012 per SGMOQ's latest filing, from $12000.0 in the prior quarter.
• Across five years, Non Operating Income topped out at $23000.0 in Q1 2011 and bottomed at -$109000.0 in Q4 2012.
• The 3-year median for Non Operating Income is $16500.0 (2010), against an average of $4200.0.
• Across the five-year window, Non Operating Income changed 0.0% in 2011 and sank 1916.67% in 2012, its largest moves.
• Year by year, Non Operating Income stood at $17000.0 in 2010, then tumbled by 64.71% to $6000.0 in 2011, then sank by 1916.67% to -$109000.0 in 2012.
• Per Business Quant, the three latest SGMOQ Non Operating Income figures stand at -$109000.0 (Q4 2012), $12000.0 (Q3 2012), and $16000.0 (Q2 2012).